{"acute myeloid leukaemia": 22.28, "anaemia": 30.72, "asthenia": 2.84, "carbohydrate antigen 125 increased": 131.76, "decreased appetite": 2.02, "disease progression": 3.33, "drug intolerance": 2.25, "drug resistance": 11.19, "dyspnoea exertional": 3.29, "haematotoxicity": 31.1, "haemoglobin abnormal": 33.38, "haemoglobin decreased": 6.62, "leukopenia": 7.55, "lymphopenia": 8.02, "maligt neoplasm progression": 22.01, "metastases to bone": 12.13, "metastases to central nervous system": 13.85, "metastases to liver": 19.64, "metastases to lung": 10.02, "metastases to lymph nodes": 17.36, "myelodysplastic syndrome": 95.59, "myelosuppression": 12.02, "nausea": 2.17, "neutropenia": 6.96, "neutrophil count decreased": 2.22, "off label use": 3.74, "ovarian cancer recurrent": 238.9, "pancytopenia": 6.33, "platelet count decreased": 3.38, "pneumonitis": 6.97, "product use in unapproved indication": 3.7, "prostatic specific antigen increased": 8.71, "red blood cell count decreased": 6.49, "thrombocytopenia": 9.23, "white blood cell count decreased": 3.77}